Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Huang, Fen  [Clear All Filters]
2019
Yan, C.-H., Liu, Q.-F., Wu, D.-P., Zhang, X., Xu, L.-P., Zhang, X.-H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2019). Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.
Han, L., Zhang, H., Chen, S., Zhou, L., Li, Y., Zhao, K., Huang, F., Fan, Z., Xuan, L., Zhang, X., et al. (2019). Intestinal microbiota can predict aGVHD following allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Xuan, L., Wang, Y., Chen, J., Jiang, E., Gao, L., Wu, B., Deng, L., Liang, X., Huang, F., Fan, Z., et al. (2019). Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT.Biol Blood Marrow Transplant.
2018
Xiao, H., Li, L., Pang, Y., Wu, Y., Jiang, Z., Liu, Z., Wu, J., Xiao, Y., Huang, F., Liu, Q., et al. (2018). Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia.Ann Hematol.
2016
Jiang, X., Xu, L., Zhang, Y., Huang, F., Liu, D., Sun, J., Song, C., Liang, X., Fan, Z., Zhou, H., et al. (2016). Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.Oncoimmunology5, e1139274.
2013
Wu, M., Huang, F., Jiang, X., Fan, Z., Zhou, H., Liu, C., Jiang, Q., Zhang, Y., Zhao, K., Xuan, L., et al. (2013). Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation.Plos One8, e77805.